Skip to main content

MoneyWorks4Me

The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 2519.48 millions.The Net Loss for the quarter ended December 2022 is Rs. -571.26 millions as compared to Net Loss of Rs. -235.00 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 further decreased to -267.30% as compared to -18.07% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 2519.48 2482.91 1.47 7623.67 6660.61 14.46 9429.27 11239.73 -16.11
Other Income 154.33 150.89 2.28 380.58 329.90 15.36 420.68 473.71 -11.19
PBIDT -267.30 -18.07 1379.25 -461.22 -230.56 100.04 -14.87 1428.38 -101.04
Interest 17.61 3.29 435.26 64.49 14.97 330.79 20.74 13.01 59.42
PBDT -284.91 -21.36 1233.85 -575.93 -245.53 134.57 -35.61 1415.37 -102.52
Depreciation 286.35 213.64 34.03 776.62 619.20 25.42 831.88 758.92 9.61
PBT -571.26 -235.00 143.09 -1352.55 -864.73 56.41 -867.49 656.45 -232.15
TAX 0.00 0.00 0.00 206.12 -137.11 -250.33 -313.18 115.63 -370.85
Deferred Tax 0.00 0.00 0.00 206.12 -139.48 -247.78 -315.55 109.43 -388.36
PAT -571.26 -235.00 143.09 -1558.67 -727.62 114.21 -554.31 540.82 -202.49
Equity 140.81 140.81 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) -10.61 -0.73 1357.72 -6.05 -3.46 74.77 -0.16 12.71 -101.24
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..